534 filings
Page 10 of 27
6-K
NVCN
Neovasc Inc
27 May 20
Current report (foreign)
12:00am
6-K
NVCN
Neovasc Inc
8 May 20
Statement of Executive Compensation
6:09am
6-K
NVCN
Neovasc Inc
8 May 20
Condensed Interim Consolidated Financial Statements
6:07am
6-K
NVCN
Neovasc Inc
8 May 20
Neovasc Announces First Quarter Financial Results
12:00am
6-K
NVCN
Neovasc Inc
1 May 20
Neovasc Announces Receipt of Nasdaq Extension to Satisfy Market Cap Rule
5:16pm
6-K
NVCN
Neovasc Inc
23 Apr 20
Current report (foreign)
8:35am
6-K
NVCN
Neovasc Inc
30 Mar 20
Neovasc Announces Fourth Quarter and Full Year 2019 Financial Results
4:08pm
20-F
2019 FY
NVCN
Neovasc Inc
Annual report (foreign)
30 Mar 20
4:08pm
6-K
NVCN
Neovasc Inc
17 Mar 20
Current report (foreign)
9:14am
6-K
NVCN
Neovasc Inc
4 Mar 20
Neovasc Updates Investors at SVB Leerink 9th Annual Global Healthcare Conference
9:02am
6-K
NVCN
Neovasc Inc
3 Mar 20
Current report (foreign)
9:05am
6-K
NVCN
Neovasc Inc
20 Feb 20
Neovasc Will Request Nasdaq Hearing After Company Received Expected Delisting Determination From Nasdaq Staff
7:21am
6-K
NVCN
Neovasc Inc
18 Feb 20
Current report (foreign)
9:00am
SC 13G/A
Magnetar Financial LLC
13 Feb 20
Neovasc Inc
12:00am
6-K
NVCN
Neovasc Inc
12 Feb 20
Neovasc Achieves Design Freeze for Transfemoral Trans-septal Tiara™ Mitral Valve System
9:31am
6-K
NVCN
Neovasc Inc
11 Feb 20
Neovasc Initiates Independent Inquiry Into Trading of its Shares
7:37am
SC 13G/A
NVCN
Neovasc Inc
6 Feb 20
Beneficial ownership report (amended)
3:53pm
6-K
NVCN
Neovasc Inc
5 Feb 20
Neovasc Announces Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer™ for Treatment of Refractory Angina
2:44pm
6-K
NVCN
Neovasc Inc
3 Feb 20
Neovasc Provides Update on Nasdaq Compliance
7:36am
6-K
NVCN
Neovasc Inc
28 Jan 20
Neovasc Announces Executive Steering Committee for Transfemoral Trans-septal Tiara Program
9:02am